CHATSWORTH, Calif., Oct. 01, 2025 (GLOBE NEWSWIRE) -- XYRA Corp., a subsidiary of Cavitation Technologies, Inc. ("CTi" or the "Company")…
New capability establishes MinIO as the on-prem Exascale AI Data Store for secure, sovereign, scalable Enterprise AI REDWOOD CITY, Calif.,…
The only unified platform for AI agent systems, enabling more accurate, real-time response against AI-driven threats SAN FRANCISCO, Sept. 30,…
SINGAPORE, Sept. 30, 2025 /PRNewswire/ -- Carrier will showcase QuantumLeap™, a comprehensive suite of purpose-built thermal management solutions for data centers,…
NEW YORK, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company focused on keeping cancer…
NEW YORK, Sept. 26, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from…
Through Week 56 in the SOLARIS trial, there were no suspected or confirmed post-injection delirium/sedation syndrome (PDSS) events observed with…
September 20, 2025 11:00 ET | Source: C4 Therapeutics, Inc. Cemsidomide in Combination With Dexamethasone Achieved a 50% Overall Response…
NORWALK, Conn., Sept. 20, 2025 (GLOBE NEWSWIRE) -- Today, the Multiple Myeloma Research Foundation® (MMRF) announced that data generated from…
SHANGHAI, Sept. 20, 2025 /PRNewswire/ -- During HUAWEI CONNECT 2025, Huawei and industry pioneers unveiled over 30 global benchmark showcases…